UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LITT
451
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$1.86M 0.03%
184,322
-1,804
-1% -$17.8K
2021 Q3
5 quarters
BTM icon
452
DELISTED
Bitcoin Depot
BTM
$1.85M 0.03%
26,007
-254
-1% -$17.7K
2022 Q2
2 quarters
HLN icon
453
Haleon
HLN
$42.6B
$1.84M 0.03%
230,154
+46,340
+25% +$315K
2022 Q3
1 quarter
ITQ
454
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$1.84M 0.03%
182,323
– –
2021 Q2
6 quarters
NFYS icon
455
DELISTED
Enphys Acquisition Corp.
NFYS
$1.83M 0.03%
182,046
-1,781
-1% -$17.6K
2022 Q2
2 quarters
ESTA icon
456
Establishment Labs
ESTA
$1.72B
$1.82M 0.03%
27,799
+9,873
+55% +$597K
2022 Q1
3 quarters
BPMC icon
457
DELISTED
Blueprint Medicines
BPMC
$1.82M 0.03%
+41,606
New +$2M
2022 Q4
0 quarters
PTC icon
458
PTC
PTC
$21B
$1.8M 0.03%
+15,000
New +$1.79M
2022 Q4
0 quarters
CNDA icon
459
DELISTED
Concord Acquisition Corp II
CNDA
$1.79M 0.03%
180,304
-1,765
-1% -$17.3K
2021 Q4
4 quarters
DEN
460
DELISTED
Denbury Inc.
DEN
$1.79M 0.03%
+20,561
New +$1.87M
2022 Q4
0 quarters
BCAB icon
461
DELISTED
BIOATLA INC
BCAB
$1.78M 0.03%
4,323
+2,083
+93% +$864K
2022 Q3
1 quarter
FAF icon
462
First American
FAF
$6.34B
$1.74M 0.03%
33,311
-55,807
-63% -$2.83M
2022 Q2
2 quarters
RAPT icon
463
DELISTED
RAPT Therapeutics
RAPT
$1.74M 0.03%
10,988
+2,261
+26% +$362K
2022 Q2
2 quarters
PHAT icon
464
Phathom Pharmaceuticals
PHAT
$599M
$1.73M 0.03%
154,093
– –
2022 Q1
3 quarters
VKTX icon
465
Viking Therapeutics
VKTX
$3.24B
$1.73M 0.03%
183,912
-63,088
-26% -$282K
2022 Q3
1 quarter
PFSI icon
466
PennyMac Financial
PFSI
$3B
$1.73M 0.03%
30,502
-48,616
-61% -$2.57M
2022 Q2
2 quarters
KIDS icon
467
OrthoPediatrics
KIDS
$581M
$1.72M 0.03%
43,282
+6,834
+19% +$285K
2022 Q1
3 quarters
LEA icon
468
Lear
LEA
$5.89B
$1.71M 0.03%
+13,748
New +$1.82M
2022 Q4
0 quarters
DY icon
469
Dycom Industries
DY
$7.84B
$1.7M 0.03%
18,116
-4,261
-19% -$429K
2022 Q2
2 quarters
THC icon
470
Tenet Healthcare
THC
$21.9B
$1.69M 0.03%
+34,626
New +$1.6M
2022 Q4
0 quarters
HHLA
471
DELISTED
HH&L Acquisition Co.
HHLA
$1.68M 0.03%
165,984
-1,625
-1% -$16.3K
2021 Q3
5 quarters
PBF icon
472
PBF Energy
PBF
$10.6B
$1.68M 0.03%
41,109
-29,949
-42% -$1.25M
2022 Q2
2 quarters
HORI
473
DELISTED
Emerging Markets Horizon Corp. Class A Ordinary Shares
HORI
$1.66M 0.03%
162,180
-1,587
-1% -$16K
2022 Q1
3 quarters
RVNC icon
474
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.65M 0.03%
89,275
-11,904
-12% -$272K
2022 Q1
3 quarters
BBBY
475
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.65M 0.03%
325,700
– –
2022 Q1
3 quarters
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.